Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Birmingham Alabama 35211

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Mobile Alabama 36607

A clinical trial to evaluate treatments for patients with Breast Cancer

UPDATED

Mobile Alabama 36604

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Arizona

UPDATED

Glendale Arizona 85304

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Tucson Arizona 85724

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Yuma Arizona 85364

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Yuma Arizona 85364

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

Arkansas

UPDATED

Fayetteville Arkansas 72703

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer or Breast Cancer

UPDATED

Little Rock Arkansas 72205

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

California

UPDATED

Additional Locations California 93901

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Beverly Hills California 90210

A clinical trial to evaluate treatments for patients with Breast Cancer

UPDATED

Fountain Valley California 92708

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Fullerton California 92835

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

La Jolla California 92093

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

View More ▼

UPDATED

Long Beach California 90813

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

UPDATED

Los Angeles California 90033

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Sacramento California 95817

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

San Francisco California 94115

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

San Francisco California 94115

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer or Breast Cancer

UPDATED

Vallejo California 94589

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

West Hills California 91307

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Colorado

UPDATED

Aurora Colorado 80045

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer or Breast Cancer

Connecticut

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

UPDATED

Southington Connecticut 06489

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Florida

UPDATED

Deerfield Beach Florida 33442

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Fort Myers Florida 33916

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Hollywood Florida 33021

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

UPDATED

Jacksonville Florida 32207

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

View More ▼

UPDATED

Miami Florida 33173

A clinical trial to evaluate treatments for patients with Breast Cancer

UPDATED

Miami Florida 33136

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

UPDATED

New Port Richey Florida 34655

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Georgia

UPDATED

Atlanta Georgia 30341

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Atlanta Georgia 30318

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Marietta Georgia 30060

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Savannah Georgia 31405

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Illinois

UPDATED

Chicago Illinois 60637

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Harvey Illinois 60426

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Peoria Illinois 60615

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Skokie Illinois 60077

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Urbana Illinois 61801

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Kentucky

UPDATED

Ashland Kentucky 41101

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

Louisiana

UPDATED

Marrero Louisiana 70072

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

New Orleans Louisiana 70121

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

New Orleans Louisiana 70112

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Maryland

UPDATED

Annapolis Maryland 21401

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Baltimore Maryland 21201

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Baltimore Maryland 21287-0013

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer